華創雲信(600155.SH):上半年淨利潤同比預增58%-73%
格隆匯7月14日丨華創雲信(600155.SH)公佈2025年半年度業績預告,預計2025年1月1日至6月30日歸屬於上市公司股東的淨利潤7,500萬元至8,200萬元,比上年同期增長58%-73%;歸屬於上市公司股東的扣除非經常性損益的淨利潤6,200萬元至6,900萬元,比上年同期增長37%-53%;2025年上半年,公司進一步加快推進數字化、智能化轉型,調整組織架構,構建協同高效的運行機制,同時通過加強成本管控,優化大類資產配置,強化實體經濟服務等措施,推動公司提質增效,提高盈利能力,取得較好效果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.